Jorma Strand

3.0k total citations · 1 hit paper
5 papers, 836 citations indexed

About

Jorma Strand is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Jorma Strand has authored 5 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Molecular Biology and 1 paper in Surgery. Recurrent topics in Jorma Strand's work include Diabetes Treatment and Management (3 papers), Metabolism, Diabetes, and Cancer (2 papers) and Diabetes Management and Research (2 papers). Jorma Strand is often cited by papers focused on Diabetes Treatment and Management (3 papers), Metabolism, Diabetes, and Cancer (2 papers) and Diabetes Management and Research (2 papers). Jorma Strand collaborates with scholars based in Denmark, Finland and United States. Jorma Strand's co-authors include Nor Azmi Kamaruddin, Stephen Colagiuri, Michael Brändle, Michel Marre, Marija Zdravković, Meng H. Tan, Vinod Mattoo, D Oakley, Loren D. Grossman and Carmen Fajardo and has published in prestigious journals such as Nephrology Dialysis Transplantation, Diabetic Medicine and Clinical Therapeutics.

In The Last Decade

Jorma Strand

5 papers receiving 784 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liraglutide, a once‐daily human GLP‐1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD‐1 SU)

2009 687 citations Michel Marre, Michael Brändle et al. Diabetic Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jorma Strand Denmark	4	759	456	281	196	66	5	836
Mario Widel United States	7	764 1.0×	430 0.9×	281 1.0×	139 0.7×	68 1.0×	11	922
Fred Yang United States	9	771 1.0×	386 0.8×	300 1.1×	166 0.8×	50 0.8×	17	867
Ken Wilhelm United States	6	874 1.2×	371 0.8×	336 1.2×	236 1.2×	75 1.1×	7	952
J.P. Courrèges France	5	672 0.9×	338 0.7×	308 1.1×	171 0.9×	75 1.1×	7	734
Marilyn K. Boardman United States	10	1.0k 1.3×	470 1.0×	358 1.3×	275 1.4×	84 1.3×	12	1.1k
Lene Jensen Denmark	9	722 1.0×	459 1.0×	330 1.2×	156 0.8×	53 0.8×	11	846
Shizuka Kaneko Japan	11	847 1.1×	400 0.9×	291 1.0×	287 1.5×	188 2.8×	23	1.0k
Andrei‐Mircea Catarig Denmark	17	899 1.2×	623 1.4×	171 0.6×	241 1.2×	115 1.7×	30	1.0k
Masakazu Takeuchi Japan	13	479 0.6×	256 0.6×	128 0.5×	130 0.7×	72 1.1×	29	550
Marie‐Louise Hartoft‐Nielsen Denmark	11	439 0.6×	237 0.5×	97 0.3×	96 0.5×	60 0.9×	17	635

Countries citing papers authored by Jorma Strand

Since Specialization

Citations

This map shows the geographic impact of Jorma Strand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorma Strand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorma Strand more than expected).

Fields of papers citing papers by Jorma Strand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorma Strand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorma Strand. The network helps show where Jorma Strand may publish in the future.

Co-authorship network of co-authors of Jorma Strand

This figure shows the co-authorship network connecting the top 25 collaborators of Jorma Strand. A scholar is included among the top collaborators of Jorma Strand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorma Strand. Jorma Strand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Rossing, Peter, Jorma Strand, Angelo Avogaro, et al.. (2020). Effects of the chymase inhibitor fulacimstat in diabetic kidney disease—results from the CADA DIA trial. Nephrology Dialysis Transplantation. 36(12). 2263–2273. 11 indexed citations

2.

Marre, Michel, Michael Brändle, Nor Azmi Kamaruddin, et al.. (2009). Liraglutide, a once‐daily human GLP‐1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD‐1 SU). Diabetic Medicine. 26(3). 268–278. 687 indexed citations breakdown →

3.

Thurén, Tom, et al.. (2006). Th-P16:259 Effect of torcetrapib combin atorvastatin on HDL-C and LDL-C levels, particle size, and composition: A phase 2 dose-ranging clinical trial. Atherosclerosis Supplements. 7(3). 550–550. 1 indexed citations

4.

Mattoo, Vinod, D.J.A. Eckland, Mario Widel, et al.. (2005). Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: Results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study. Clinical Therapeutics. 27(5). 554–567. 79 indexed citations

5.

Tan, Meng H., Don Johns, Jorma Strand, et al.. (2004). Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes. Diabetic Medicine. 21(8). 859–866. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact